Table 7.
Change over baseline |
95% CI |
||||
---|---|---|---|---|---|
Treatment | M | SD | Lower | Upper | Significant |
VO2 | |||||
CON | −1.5 | 5.7 | −3.7 | 0.7 | 0.188 |
FREE | −2.0 | 5.6 | −3.9 | −0.1 | 0.037* |
PAC | −3.2 | 6.4 | −6.0 | −0.3 | 0.031* |
STRUC | −1.9 | 6.4 | −4.1 | 0.5 | 0.113 |
MAP | |||||
CON | 0.3 | 7.3 | −2.2 | 2.9 | 0.792 |
FREE | 1.9 | 6.6 | −0.1 | 3.9 | 0.065 |
PAC | 1.5 | 5.8 | −0.7 | 3.7 | 0.183 |
STRUC | 1.3 | 8.0 | −1.2 | 3.9 | 0.288 |
CHOL | |||||
CON | −0.2 | 0.5 | −0.4 | 0.0 | 0.014* |
FREE | 0.1 | 0.5 | −0.1 | 0.2 | 0.313 |
PAC | 0.0 | 0.6 | −0.2 | 0.3 | 0.820 |
STRUC | 0.0 | 0.5 | −0.1 | 0.2 | 0.880 |
*Statistically significant difference between treatment groups where α was set at 0.05.
CHOL, cholesterol; CONT, control condition; FREE, unstructured gym exercise; MAP, mean arterial pressure; PAC, physical activity counseling; STRUC, structured gym exercise programme; TC, total cholesterol.